BioGrid is supporting Generation Victoria's 'Big Idea'. Our expertise is supporting the linkage of stored residual clinical biosamples to GenV participants, acting as a ‘secure bridge’ between pathology providers and GenV.

Read more on how BioGrid helped: https://www.biogrid.org.au/genv

BioGrid's experience in developing registry software to meet both clinician and researcher requirements was leveraged for the development of the centralised PURPLE registry.

Learn more about why BioGrid is integral to PURPLE’s #pancreaticcancer #research.

https://www.biogrid.org.au/purple

Breast cancer is the second most commonly diagnosed cancer in Australia. The BREAST registry, developed by BioGrid, aims to improve understanding of the treatment and outcomes of breast cancer patients.

Read the case study: https://www.biogrid.org.au/breast-registry
#research #breastcancer

#pancreaticcancer is the third most common cause of cancer death in Australia and is predicted to become the second leading cause of cancer deaths globally by 2030.

BioGrid is supporting the PURPLE program to combat these alarming statistics.

Learn more: www.biogrid.org.au/purple

🎉 Congratulations to Professor Karin Thursky the inaugural Director of Peter Mac’s Centre for Health Services Research in Cancer!

Learn more: https://www.biogrid.org.au/thursky-director-hsrc
@petermaccc.bsky.social

Breast cancer is not one disease, it has three distinct subtypes making treatment complex. Real-world evidence is vital to complement clinical trial data. That's why BioGrid developed the BREAST Registry.

Read the full case study with Dr Sheau Wen Lok: https://www.biogrid.org.au/breast-registry